Achieved Record High Revenue of HK$273.6M and Net Profit of HK$67.4M Further Penetration to Osteoporosis, Ophthalmology, and Medical Aesthetic Device Markets
2024-08-28
View details
Recently, Uni-Bio Science Group Limited is pleased to announce a strategic cooperation with Chongqing Minji Medical Device Co., Ltd.
2024-07-10
View details
Record-breaking Revenue of HK$484.7M and Net Profit of HK$70.9M，Pioneering Breakthroughs in Osteoporosis, Medical Aesthetics, and Ophthalmology Markets
2024-03-28
View details
Uni-Bio Science Group Limited is pleased to announce the acceptance of its marketing application for Diquafosol Sodium eye drops by the China National Medical Products Administration (“NMPA”) on 23 January 2024, with the acceptance number “CYHS2400318“.
2024-01-23
View details
Uni-Bio Science Group Limited is excited to announce that the China National Medical Products Administration ("NMPA") has officially approved the marketing application for BOGUTAI® (teriparatide injection) on January 16, 2024. This significant milestone h
2024-01-22
View details
